Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health
Launched by M.D. ANDERSON CANCER CENTER · May 22, 2024
Trial Information
Current as of November 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how social and financial factors can affect the outcomes of transplant and cell therapy (TCT) treatments at MD Anderson. Researchers want to understand how things like a patient's income, support systems, and overall living conditions might influence their recovery and success after these treatments.
To participate in this study, you need to be at least 18 years old and have received financial approval for your TCT. If you join, you'll be part of a group that helps researchers gather important information about how different life circumstances can impact health outcomes. This study is currently recruiting participants of all genders, and it aims to shine a light on factors that could help improve care for future patients.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • 1. ≥ 18 years of age.
- • 2. Received financial clearance for TCT.
- • Qualitative study - patients
- • 1. Patient ≥ 18 years of age who is currently cared for at MD Anderson as a TCT candidate/ recipient,
- • 2. The patient reports social and/or financial challenges impacting care delivery.
- • 3. The patient is willing to participate in a semi-structured interview.
- • Qualitative study - caregivers
- • 1. Caregiver(s) of a patient ≥ 18 years of age who is currently cared for at MD Anderson as a TCT candidate/ recipient.
- • 2. The patient reports social and/or financial challenges impacting care delivery.
- • 3. The patient has referred the caregiver(s) to participate and provided us with permission to contact their caregiver(s).
- • 4. The caregiver(s) is (are) willing to participate in a semi-structured interview.
- • Exclusion Criteria Patients - Quantitative study 1) Did not receive financial clearance for TCT
- • Patients - Qualitative study
- • 1) Not impacted by social or financial challenges.
- • Caregivers (qualitative study)
- • 1. Did not care for a patient impacted by social or financial challenges
- • 2. Were not referred to participate in the study by patient they cared for.
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Warren Fingrut, MD
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported